Research with over 35,000 students shows that the relationship between cannabis and anxiety or depression intensified between 2013 and 2023, especially among girls and frequent users

Studies compiled in the Sechat Cannabis Guide show therapeutic benefits of CBD and acidic cannabinoids in horses, wildlife, and unconventional pets

Research conducted by a United States university observed cognitive improvement and reduction of disease markers in animal models from the combination of THC and an anti-inflammatory medication

Resolution No. 1,015/2026 tightens technical requirements, expands sanitary controls, and consolidates authorization as a transitional step before the registration of medicines

New RDC No. 1,011 expands regulatory details on Cannabis derivatives, medicinal products, and pharmaceutical inputs

Bipartisan proposal considers that the already consolidated market can be controlled by clear rules, instead of being banned in the state

Coalition accuses retailers of selling marijuana as hemp and operating outside the regulated market

Deusa Cast episode addresses safety, oversight, and the role of compounding pharmacy in building personalized treatments, including medical cannabis

Regulatory advances and scientific potential put the country on the radar of international investors and consolidate the veterinary sector

Campaign reinforces the importance of early diagnosis and points to medical cannabis as an ally in symptom management and quality of life for patients

Experts discuss the gap in medical training, the role of nutrition, and how lifestyle habits modulate the endocannabinoid system in disease prevention.

Anvisa proposes exclusive process for the regulation and experts point out impact on the sector

Argentinian government decrees promote administrative changes in the state structure, keeping the legislation on medicinal cannabis in the country in force

A double-blind, placebo-controlled clinical trial evaluated different formulations of vaporized cannabis for the acute treatment of migraine.

Expert explains why dogs and cats may be interested in plants and provides simple measures to prevent ingestion and preserve animal safety

Despite technical feasibility, Anvisa conditions the production of cannabidiol on the publication of a specific regulation, with validity in 90 days

The topic was discussed during a lecture at the 43rd CIOSP, the largest dentistry congress in Latin America, focusing on scientific evidence and the impacts of Anvisa's new regulations on dental practice in the treatment of orofacial pain.

The topic was discussed during a lecture at the 43rd CIOSP, the largest dentistry congress in Latin America, focusing on scientific evidence and the impacts of Anvisa's new regulation on dental practice in the treatment of orofacial pain

The change in federal legislation recognizes the medical use of cannabis, but does not alter the rules for recreational consumption or the national prohibition

CBN and CBC stand out as minor cannabinoids with therapeutic potential to improve sleep, relieve pain, and modulate inflammatory processes

Preservation of cannabinoids and treatment effectiveness directly depend on strict control of light and humidity

Work brings together science, real stories, and regulatory experience to demystify medicinal cannabis

Cannabis Fair 2026, taking place from May 21 to 23 in São Paulo, will bring together companies, researchers, and investors, highlighting the industrial, technological, and regulatory advancements of cannabis in Brazil

Pharmaceutical entities challenge in the Supreme Court the exclusivity of hospitals in dispensing magistral formulas based on medicinal cannabis, as provided in a recent decree

Agency defines a modular strategy for cannabis cultivation, establishing distinct rules for patient associations, research, and industry

Revision of RDC 327 allows the compounding sector to produce derivatives, while individual importation by individuals remains under old rules and will be analyzed separately

Anvisa's proposal establishes a new regulatory framework for industrialized medicinal cannabis products in Brazil

Anvisa directors meet this Wednesday (28) to discuss the update of medicinal cannabis regulations; learn how to follow

Anvisa directors meet this Wednesday (28) to discuss the update of medicinal cannabis regulations; learn how to follow

Proposal authorizes companies to cultivate plants with up to 0.3% THC exclusively for the production of medicinal inputs, but experts warn of the technical unfeasibility of the limit in a tropical climate